Jamieson Wellness Inc (JWEL) Given Average Recommendation of “Buy” by Analysts

Jamieson Wellness Inc (TSE:JWEL) has been assigned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year is C$23.05.

JWEL has been the subject of several recent research reports. Royal Bank of Canada boosted their price objective on Jamieson Wellness from C$22.00 to C$23.00 and gave the company an “outperform” rating in a research report on Friday, November 10th. BMO Capital Markets reiterated an “outperform” rating and issued a C$22.00 price objective on shares of Jamieson Wellness in a research report on Friday, November 10th. CIBC boosted their price objective on Jamieson Wellness from C$19.00 to C$20.60 in a research report on Thursday, November 2nd. Canaccord Genuity reiterated a “buy” rating and issued a C$24.00 price objective on shares of Jamieson Wellness in a research report on Monday, October 30th. Finally, TD Securities boosted their price objective on Jamieson Wellness from C$22.00 to C$24.00 and gave the company a “buy” rating in a research report on Monday, November 13th.

In related news, Director David Michael Williams acquired 1,500 shares of the stock in a transaction on Friday, November 24th. The stock was purchased at an average price of C$21.55 per share, for a total transaction of C$32,325.00.

Shares of Jamieson Wellness (JWEL) opened at C$21.99 on Friday. The firm has a market capitalization of $834.06 and a P/E ratio of -17.88. Jamieson Wellness has a 12-month low of C$16.44 and a 12-month high of C$22.76.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 15th. Shareholders of record on Friday, December 15th were given a $0.08 dividend. The ex-dividend date was Thursday, November 30th. This represents a $0.32 annualized dividend and a yield of 1.46%. Jamieson Wellness’s payout ratio is currently -6.50%.

COPYRIGHT VIOLATION NOTICE: “Jamieson Wellness Inc (JWEL) Given Average Recommendation of “Buy” by Analysts” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.com-unik.info/2018/01/13/jamieson-wellness-inc-jwel-given-average-recommendation-of-buy-by-analysts.html.

Jamieson Wellness Company Profile

Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands as well as sports nutrition products through Progressive, Precision and Iron Vegan brands.

Analyst Recommendations for Jamieson Wellness (TSE:JWEL)

Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit